Neurobiological and Genomic Predictors of Relapse in Depression
Recruiting
Observational Study
Healthy
Major Depressive Disorder (MDD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 204 (estimated)
- Sponsor
- Mehmet Kemal Arikan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to test whether the discontinuation of antidepressant medications for patients with depression can be decided after the normalization of biological parameters. The main questions it aims are:
1. When patients with depression treated with antidepressants, does their brain activity also become normal? If so,
2. Then, can we stop the antidepressant treatment a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Outpatients
* For patients, satisfying Major Depressive Disorder for Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR)
* Drug-free for at least 1-week
Exclusion Criteria:
* Any neurological and psychiatric comorbid conditions
* Hearing loss
* Physical diseases
Contacts